In conclusion, our study described a fundamental mechanism responsible for the progression of pancreatic cancer, and identified key targets in the SYT8-mediated pathway that were directly related to disease progression, thereby providing the basis for the development of therapeutic targets to reduce the severity of disease and metastasis in patients. Here, SYT8 is linked to pancreatic neoplasm.